Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Recurrent Gastrointestinal Stromal Tumor

The reemergence of a gastrointestinal stromal tumor after a period of remission.
National Institutes of Health

Related topics

Related topics

14 relations
C-KIT GeneConnective Tissue CellsConnective and Soft TissueInterstitial Cells of Cajal
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse…
ABSTRACT Gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit is a rare type of sarcoma. The aim of… Expand
2016
2016
Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy
BackgroundNilotinib inhibits the tyrosine kinase activities of ABL1/BCR-ABL1, KIT, and platelet-derived growth factor receptors… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2014
2014
Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
OBJECTIVES: Despite its rising popularity, reports on the use of preoperative imatinib mesylate (IM) in patients with advanced… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
2013
2013
Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report
Unexpected clinical and/or imaging evidence of the recurrence of gastrointestinal stromal tumors soon after surgical resection… Expand
  • figure 1
  • figure 2
  • figure 5
  • figure 3
  • figure 4
2013
2013
Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor
AbstractIntra-abdominal fibromatosis (IAF) commonly develops in patients who had abdominal surgery. In rare instances, it occurs… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2009
2009
A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome
BackgroundAbout 80% of patients with GIST would experience tumor recurrence or metastasis after radical resection. The most… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
2008
2008
Perforation of the colon by invading recurrent gastrointestinal stromal tumors during sunitinib treatment.
The molecular targets of sunitinib are receptor tyrosine kinases (RTKs), and this drug has also been known to exert blocking… Expand
2008
2008
Gastric carcinoid tumor in a patient with a past history of gastrointestinal stromal tumor of the stomach.
Gastrointestinal stromal tumor is the most common mesenchymal tumor in the gastrointestinal tract. It may coexist with other type… Expand
2006
2006
Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment
A 57-year-old man with gastrointestinal stromal tumor (GIST) of the stomach with peritoneal dissemination underwent gastrectomy… Expand
  • figure 1
  • figure 2
  • figure 3
2004
2004
High efficacy of imatinib for recurrent gastrointestinal stromal tumor in the jejunum: a case report.
Gastrointestinal stromal tumor is a mesenchymal tumor of the digestive tract. Although there used to be no effective therapy for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE